TY - JOUR
T1 - Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty
T2 - randomised clinical trial
AU - Gasbjerg, Kasper Smidt
AU - Hägi-Pedersen, Daniel
AU - Lunn, Troels Haxholdt
AU - Laursen, Christina Cleveland
AU - Holmqvist, Majken
AU - Vinstrup, Louise Ørts
AU - Ammitzboell, Mette
AU - Jakobsen, Karina
AU - Jensen, Mette Skov
AU - Pallesen, Marie Jøhnk
AU - Bagger, Jens
AU - Lindholm, Peter
AU - Pedersen, Niels Anker
AU - Schrøder, Henrik Morville
AU - Lindberg-Larsen, Martin
AU - Nørskov, Anders Kehlet
AU - Thybo, Kasper Højgaard
AU - Brorson, Stig
AU - Overgaard, Søren
AU - Jakobsen, Janus Christian
AU - Mathiesen, Ole
N1 - © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2022/1/4
Y1 - 2022/1/4
N2 - OBJECTIVE: To investigate the effects of one and two doses of intravenous dexamethasone in patients after total knee arthroplasty.DESIGN: Randomised, blinded, placebo controlled trial with follow-up at 90 days.SETTING: Five Danish hospitals, September 2018 to March 2020.PARTICIPANTS: 485 adult participants undergoing total knee arthroplasty.INTERVENTION: A computer generated randomised sequence stratified for site was used to allocate participants to one of three groups: DX1 (dexamethasone (24 mg)+placebo); DX2 (dexamethasone (24 mg)+dexamethasone (24 mg)); or placebo (placebo+placebo). The intervention was given preoperatively and after 24 hours. Participants, investigators, and outcome assessors were blinded. All participants received paracetamol, ibuprofen, and local infiltration analgesia.MAIN OUTCOME MEASURES: The primary outcome was total intravenous morphine consumption 0 to 48 hours postoperatively. Multiplicity adjusted threshold for statistical significance was P<0.017 and minimal important difference was 10 mg morphine. Secondary outcomes included postoperative pain.RESULTS: 485 participants were randomised: 161 to DX1, 162 to DX2, and 162 to placebo. Data from 472 participants (97.3%) were included in the primary outcome analysis. The median (interquartile range) morphine consumptions at 0-48 hours were: DX1 37.9 mg (20.7 to 56.7); DX2 35.0 mg (20.6 to 52.0); and placebo 43.0 mg (28.7 to 64.0). Hodges-Lehmann median differences between groups were: -2.7 mg (98.3% confidence interval -9.3 to 3.7), P=0.30 between DX1 and DX2; 7.8 mg (0.7 to 14.7), P=0.008 between DX1 and placebo; and 10.7 mg (4.0 to 17.3), P<0.001 between DX2 and placebo. Postoperative pain was reduced at 24 hours with one dose, and at 48 hours with two doses, of dexamethasone.CONCLUSION: Two doses of dexamethasone reduced morphine consumption during 48 hours after total knee arthroplasty and reduced postoperative pain.TRIAL REGISTRATION: Clinicaltrials.gov NCT03506789.
AB - OBJECTIVE: To investigate the effects of one and two doses of intravenous dexamethasone in patients after total knee arthroplasty.DESIGN: Randomised, blinded, placebo controlled trial with follow-up at 90 days.SETTING: Five Danish hospitals, September 2018 to March 2020.PARTICIPANTS: 485 adult participants undergoing total knee arthroplasty.INTERVENTION: A computer generated randomised sequence stratified for site was used to allocate participants to one of three groups: DX1 (dexamethasone (24 mg)+placebo); DX2 (dexamethasone (24 mg)+dexamethasone (24 mg)); or placebo (placebo+placebo). The intervention was given preoperatively and after 24 hours. Participants, investigators, and outcome assessors were blinded. All participants received paracetamol, ibuprofen, and local infiltration analgesia.MAIN OUTCOME MEASURES: The primary outcome was total intravenous morphine consumption 0 to 48 hours postoperatively. Multiplicity adjusted threshold for statistical significance was P<0.017 and minimal important difference was 10 mg morphine. Secondary outcomes included postoperative pain.RESULTS: 485 participants were randomised: 161 to DX1, 162 to DX2, and 162 to placebo. Data from 472 participants (97.3%) were included in the primary outcome analysis. The median (interquartile range) morphine consumptions at 0-48 hours were: DX1 37.9 mg (20.7 to 56.7); DX2 35.0 mg (20.6 to 52.0); and placebo 43.0 mg (28.7 to 64.0). Hodges-Lehmann median differences between groups were: -2.7 mg (98.3% confidence interval -9.3 to 3.7), P=0.30 between DX1 and DX2; 7.8 mg (0.7 to 14.7), P=0.008 between DX1 and placebo; and 10.7 mg (4.0 to 17.3), P<0.001 between DX2 and placebo. Postoperative pain was reduced at 24 hours with one dose, and at 48 hours with two doses, of dexamethasone.CONCLUSION: Two doses of dexamethasone reduced morphine consumption during 48 hours after total knee arthroplasty and reduced postoperative pain.TRIAL REGISTRATION: Clinicaltrials.gov NCT03506789.
U2 - 10.1136/bmj-2021-067325
DO - 10.1136/bmj-2021-067325
M3 - Article
C2 - 34983775
SN - 0959-8146
VL - 376
SP - e067325
JO - BMJ
JF - BMJ
ER -